DK1226176T3 - Produktion af brystsekret-antistoffer i landbrugsdyr - Google Patents

Produktion af brystsekret-antistoffer i landbrugsdyr

Info

Publication number
DK1226176T3
DK1226176T3 DK00980089T DK00980089T DK1226176T3 DK 1226176 T3 DK1226176 T3 DK 1226176T3 DK 00980089 T DK00980089 T DK 00980089T DK 00980089 T DK00980089 T DK 00980089T DK 1226176 T3 DK1226176 T3 DK 1226176T3
Authority
DK
Denmark
Prior art keywords
breast
production
animal
compositions
agricultural animals
Prior art date
Application number
DK00980089T
Other languages
English (en)
Inventor
Sang He Lee
Original Assignee
Mucovax Holding B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mucovax Holding B V filed Critical Mucovax Holding B V
Application granted granted Critical
Publication of DK1226176T3 publication Critical patent/DK1226176T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK00980089T 1999-11-01 2000-10-31 Produktion af brystsekret-antistoffer i landbrugsdyr DK1226176T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16275299P 1999-11-01 1999-11-01
EP00202709 2000-07-27

Publications (1)

Publication Number Publication Date
DK1226176T3 true DK1226176T3 (da) 2006-06-06

Family

ID=26072559

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00980089T DK1226176T3 (da) 1999-11-01 2000-10-31 Produktion af brystsekret-antistoffer i landbrugsdyr

Country Status (14)

Country Link
EP (1) EP1226176B1 (da)
JP (1) JP4668499B2 (da)
KR (1) KR100627635B1 (da)
AT (1) ATE317400T1 (da)
AU (1) AU779776B2 (da)
CA (1) CA2389582C (da)
CY (1) CY1105024T1 (da)
DE (1) DE60025945T2 (da)
DK (1) DK1226176T3 (da)
ES (1) ES2258483T3 (da)
HK (1) HK1048323B (da)
NZ (1) NZ518638A (da)
PT (1) PT1226176E (da)
WO (1) WO2001032713A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1806970A4 (en) * 2004-10-06 2011-06-29 Agri Biotech Pty Ltd METHOD OF PRODUCTION OF MILK
JP2008515813A (ja) * 2004-10-06 2008-05-15 アグリ−バイオテック ピーティーワイ リミテッド 抗体産生方法
AU2005291856B2 (en) * 2004-10-06 2011-05-12 Agri-Biotech Pty Ltd Antibody production method
BRPI0906060A2 (pt) 2008-02-28 2015-12-01 3M Innovative Properties Co anticorpos isolados, métodos de preparo de um anticorpo anti-clostridium difficile, composição e método para a detecção da presença de um esporo de clostridium difficile em uma amostra

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ201698A (en) * 1981-08-31 1985-12-13 S L Gaffin Composition of antibodies specific to endotoxins
US4944942A (en) * 1987-08-27 1990-07-31 Mobay Corporation Intranasal vaccination of horses with inactivated microorganisms or antigenic material
JPH0892108A (ja) * 1994-09-19 1996-04-09 Mitsubishi Chem Corp ヒトロタウイルス下痢症に対する予防および治療薬
JPH11510793A (ja) * 1995-07-07 1999-09-21 オラバックス インク． 胃腸病に対する鼻腔内ワクチン接種
US6616927B2 (en) * 1997-05-29 2003-09-09 Agresearch Limited Processes for production of immunoglobulin A in milk

Also Published As

Publication number Publication date
DE60025945T2 (de) 2006-09-28
JP4668499B2 (ja) 2011-04-13
EP1226176A1 (en) 2002-07-31
CY1105024T1 (el) 2010-03-03
CA2389582C (en) 2010-08-31
AU1739001A (en) 2001-05-14
WO2001032713A1 (en) 2001-05-10
CA2389582A1 (en) 2001-05-10
KR100627635B1 (ko) 2006-09-25
PT1226176E (pt) 2006-06-30
ATE317400T1 (de) 2006-02-15
EP1226176B1 (en) 2006-02-08
ES2258483T3 (es) 2006-09-01
HK1048323B (en) 2006-04-28
JP2003513106A (ja) 2003-04-08
NZ518638A (en) 2003-10-31
DE60025945D1 (de) 2006-04-20
AU779776B2 (en) 2005-02-10
HK1048323A1 (en) 2003-03-28
KR20020065497A (ko) 2002-08-13

Similar Documents

Publication Publication Date Title
ATE200679T1 (de) Neues verfahren zur herstellung von anti-humanen antigenrezeptoren und deren verwendungen
BR9809656A (pt) Composição imunopotencializante
CY1107628T1 (el) Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
IL221708A0 (en) Polyclonal goat anti-hla class ii antibody for treatment of disease involving proliferative immune response
AU9399501A (en) Therapeutic antibodies
DK121683A (da) Fremgangsmaade til fremstilling af immunoenzymatiske konjugater
ATE317267T1 (de) Impfstoffe mit erhöhter immunantwort und verfahren zur deren herstellung
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
WO2005037190A3 (en) Multiplex vaccines
ATE476992T1 (de) Neutralisierbares epitop von hgf und an dieses bindende neutralisierender antikörper
CY1113243T1 (el) Μεθοδοι θεραπειας με χρηση αντισωματων cτlα-4
CY1107390T1 (el) Εμβολιο εναντι αντιγονων απο βακτηριδια
EP1088573A3 (en) Method and a video game system of generating a field map
MX374897B (es) Novedoso polipeptido y procedimiento de produccion de imp mediante el uso del mismo
ATE348633T1 (de) Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen
WO2001081609A3 (en) Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
AP9400683A0 (en) Vaccines.
IS4922A (is) Fjölpeptíð sem geta myndað formgerðir mótefnisvakabindinga með sérvirkni fyrir resus D mótefnisvaka, DNA-ið sem táknar þau og aðferðin til að búa þautil og notkun
NL7707939A (nl) Preparaat voor het opwekken van de bevalling, voor een vergemakkelijking van de bevruchting en een verhoging van de melkproduktie bij mensen en zoogdieren, vooral bij melkvee.
DK1226176T3 (da) Produktion af brystsekret-antistoffer i landbrugsdyr
WO2002034287A3 (en) Therapeutic vaccine formulations containing chitosan
ATE348842T1 (de) Anti-pilyrosporum ovale igy und dessen verwendung
DE59608073D1 (de) Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid
FR2868781B1 (fr) Composition de vaccin comprenant un ligand cmh de classe ii couple a un antigene, procede de preparation et utilisations
ATE207119T1 (de) Die herstellung von menschlichen, monoklonalen antikörpern, die gegen das oberflächenantigen von hepatitis b aktiv sind